Pursuant to Regulation 30 of SEBI Regulations, 2015 read with Para A of Part (Listing A Obligations and Disclosure Requirements) of Schedule III to the said Regulations, Earum Pharmaceuticals has informed that Bhavesh N. Sonesara has resigned from the position of the Independent Director of the Company with effect from 9th June, 2022. Further, the Company has received confirmation from Bhavesh N. Sonesara that there are no other material reasons for his resignation other than those which are provided in the resignation letter.
The above information is a part of company’s filings submitted to BSE.
